Product Images Levetiracetam
View Photos of Packaging, Labels & Appearance
- Chemical Structure - levetiracetam 01
- Figure 1 - levetiracetam 02
- Figure 2 - levetiracetam 03
- Figure 3 - levetiracetam 04
- Figure 4 - levetiracetam 05
- Figure 5 - levetiracetam 06
- Figure 6 - levetiracetam 07
- Logo - levetiracetam 08
- PRINCIPAL DISPLAY PANEL - 5 mL Vial Label - levetiracetam 09
- PRINCIPAL DISPLAY PANEL - 5 mL Vial Carton - levetiracetam 10
Product Label Images
The following 10 images provide visual information about the product associated with Levetiracetam NDC 0409-1886 by Hospira, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - levetiracetam 01
Figure 1 - levetiracetam 02
This document appears to be a statistical summary of the results of clinical trials comparing the effects of placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day on patient outcomes. The percentages shown relate to different aspects of the patient sample, but further details can be gleaned from the original source.*
Figure 2 - levetiracetam 03
This text provides information regarding the comparison of a placebo group (N=111) with two different doses of Levetiracetam, 1000 mg/day (N=106) and 2000 mg/day (N=105). The study appears to be evaluating the effects of these dosages on a certain condition or outcome.*
Figure 3 - levetiracetam 04
Figure 4 - levetiracetam 05
Not available.*
Figure 5 - levetiracetam 06
Levetiracetam is a medication with a dosage of 5% 43.1% 19.6%.*
Figure 6 - levetiracetam 07
This appears to be a summary of percentages, likely related to some data comparison or evaluation. The text mentions 100%, 0%, s0%, 0%, along with numbers like 45.2% and 72.2%, and the label "Placebo (N=84)" which might indicate a comparison group or condition. The context of these percentages is not entirely clear, suggesting that further details would be needed to fully understand the information provided.*
Logo - levetiracetam 08
PRINCIPAL DISPLAY PANEL - 5 mL Vial Label - levetiracetam 09
This is a description of a single-dose vial containing 5mL of Levetiraceta Injection USP with a concentration of 500 mg/5 mL (100 mg/mL). It is intended for intravenous use only and must be diluted before administration. The recommended storage temperature is between 20 to 25°C. The manufacturer is Gland Pharma Limited in India, and the product is manufactured for Hospira, Inc. in Lake Forest, Illinois, USA. Unused portions should be discarded. For detailed description and dosage information, refer to the package insert.*
PRINCIPAL DISPLAY PANEL - 5 mL Vial Carton - levetiracetam 10
This is a description of a medication called Levetiracetam injection in single-dose vials containing 500 mg/5 mL (100 mg/mL). The medication is designated for intravenous use only and must be diluted before administration. Each vial has a discard instruction for any unused portion. The storage temperature recommendation is between 20 to 25°C. The manufacturer is Gland Pharma Limited located in Hyderabad, India, and it is manufactured for Hospira in Lake Forest, USA. The National Drug Code (NDC) for this product is NDC0409-1886-02.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
